Feature Channels:

Blood Disorders

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Artificial Blood Vessels Developed in the Lab Can Grow with the Recipient

tranquillo_implantphoto.jpg

In a groundbreaking new study led by University of Minnesota biomedical engineers, artificial blood vessels bioengineered in the lab and implanted in young lambs are capable of growth within the recipient. If confirmed in humans, these new vessel grafts would prevent the need for repeated surgeries in some children with congenital heart defects.

Medicine

Channels:

Earlier Treatment with Surgery to Remove Blood Clot Linked with Less Disability Following Stroke

In an analysis that included nearly 1,300 patients with large-vessel ischemic stroke, earlier treatment with endovascular thrombectomy (intra-arterial use of a micro-catheter or other device to remove a blood clot) plus medical therapy (use of a clot dissolving agent) compared with medical therapy alone was associated with less disability at 3 months, according to a study appearing in the September 27 issue of JAMA.

Medicine

Channels:

NCCN, National Comprehensive Cancer Network, nccn clinical practice guidelines in oncology, nccn guidelines, Myeloproliferative Neoplasms, Cancer, Oncology, Hematology, Mayo Clinic, Cancer Treatment, Blood Cancer

NCCN Publishes New Clinical Practice Guidelines for Myeloproliferative Neoplasms

NCCNGuidelines_MPN_12017.jpg

New NCCN Guidelines for Myeloproliferative Neoplasms focus on the treatment of Myelofibrosis, a rare bone marrow cancer; the new recommendations are the most comprehensive treatment guidance available to U.S. clinicians today.

Medicine

Science

Channels:

American Thyroid Association's 2016 Van Meter Award Lecture Delivered by Robin P. Peeters, MD, PhD

The American Thyroid Association (ATA) is proud to announce that the 2016 Van Meter Award recipient is Robin P. Peeters, MD, PhD, Professor of Internal Medicine and Head of the Thyroid Laboratory at Erasmus Medical Center, Rotterdam, The Netherlands, and Director of the Rotterdam Thyroid Center, which he founded in 2011. Dr. Peeters presents the Van Meter Award Lecture, titled “How to define optimal thyroid function?” at the ATA's 86th Annual Meeting, on Saturday, September 24, 2016, in Denver, Colorado.

Science

Channels:

Thyroid Disease

American Thyroid Association Announces Recipient of the 2016 Distinguished Service Award

The American Thyroid Association (ATA) has announced that the recipient of the 2016 Distinguished Service Award is Gregory A. Brent, M.D., Professor of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, and Chair, Department of Medicine at VA Greater Los Angeles Healthcare System. The ATA will present the award to Dr. Brent at its 86th Annual Meeting, September 21-25, 2016, in Denver, Colorado.

Science

Channels:

Thyroid Disease

Latest Advances in Clinical Thyroid Research Presented at American Thyroid Association Annual Meeting

Leading clinicians and scientists from around the globe came together to share and discuss the most recent research data to help improve the care of patients with thyroid disease at the upcoming 86th Annual Meeting of the American Thyroid Association (ATA), September 21-25, 2016, in Denver, Colorado. Among the many oral and poster presentations delivered at the ATA meeting that highlighted advances in clinical research are a select few described below.

Science

Channels:

Thyroid Disease

American Thyroid Association Announces Recipient of the 2016 Lewis E. Braverman Lectureship Award

The American Thyroid Association (ATA) has announced that the recipient of the 2016 Lewis E. Braverman Lectureship Award is P. Reed Larsen, M.D., a member of the Thyroid Section, Division of Endocrinology, Diabetes and Hypertension, at Brigham and Women's Hospital, and Professor of Medicine at Harvard Medical School, Boston, MA. Dr. Larsen will deliver the Lewis E. Braverman Lecture, entitled "Deiodinases, Cofactors & the Low T3 Syndrome," at the ATA's 86th Annual Meeting, September 21-25, 2016, in Denver, Colorado. The Lewis E. Braverman Lectureship Award recognizes an individual who has demonstrated excellence and passion for mentoring fellows, students and junior faculty, has a long history of productive thyroid research, and is devoted to the ATA. The award is endowed by contributions to honor Dr. Lewis E. Braverman.

Medicine

Science

Life

Business

Law and Public Policy

Channels:

Presidential Debate: Expert Panel Gives Scientific Analysis of Candidates' Performances

Four expert panelists each day will present their analyses and answer your questions live and face-to-face. This event will be virtual. You can attend with any device -- PC, Mac, iPad, iPhone or Android device (with a webcam) – anywhere with good bandwidth. To participate (ask questions) in the meeting, you must be on video, just as a normal news conference. Register below for guaranteed seating; there is limited seating in the virtual room. Eight experts (four at each event) will present their analyses. The diverse expert team (7 universities and an institute) will analyze both candidates during the debates for their gestures, facial expressions (including smiles--number, type, appropriateness, etc.), posture, language, including sentiment, tone, inflammatory language, repetition, vocabulary, sentence structure, metaphors, framing, themes, suggestions, subtlety, nuance, honesty (deceit/lies—explicit and implicit), transparency, gender issues, and more...

Medicine

Channels:

thyroidology, Thyroid Disease

Plenary and Award Lectures, Latest Research on Thyroid Disease and Cancer, Hot Topic Debates, and Oral and Poster Presentations Featured at American Thyroid Association Annual Meeting

Key opinion leaders, thyroid specialists, clinical and basic researchers, and young trainees will come together for five exciting and information-filled days of symposia, scientific presentations, and discussions on the latest advances in thyroidology and clinical management of thyroid disease as members of the American Thyroid Association (ATA) gather in Denver, Colorado for the 86th Annual Meeting of the ATA. With nearly 1300 registered attendees to date, and 395 regular abstracts and 77 late breaking abstracts submitted, the meeting promises to be an outstanding educational and networking opportunity.

Medicine

Channels:

Cancer, Hematology, Clinical Trials, Blood Cancer

At Bat Against Rare Blood Cancers

wieduwilt_symposium.jpg

University of California researchers to hold meeting in San Diego to discuss hematologic malignancies as part of the University of California Hematologic Malignancies Consortium, a first-of-its-kind research group that brings together the five UC health campuses conducting clinical studies for cancer patients.

Medicine

Channels:

Size Is Everything When It Comes to High Blood Pressure

Hypertensionarticle.jpg

The size of a grain of rice, the carotid body, located between two major arteries that feed the brain with blood, has been found to control your blood pressure.

Medicine

Channels:

Heparin, Clots, Blood Clots, Aspirin, Trauma, Death, Fracture

Largest-Ever Study to Compare Medications to Prevent Life-Threatening Clots in Orthopaedic Trauma Patients

Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. To reduce this risk, doctors have prescribed low molecular weight heparin. But some researchers argue that aspirin may be just as effective. A comprehensive new study will try to resolve this question.

Medicine

Channels:

Hypertension, Sprint, Systolic Blood Pressure Intervention Trial, High Blood Pressure

Lowering Systolic Blood Pressure Would Save More Than 100,000 Lives Per Year, Study Finds

Intensive treatment to lower systolic (top number) blood pressure to below 120 would save more than 100,000 lives per year in the United States. Two thirds of the lives saved would be men and two thirds would be aged 75 or older.

Medicine

Channels:

bone marrow transtplant, be the match registry, Leukemia, Acute Lymphoblastic Leukemia, All

Leukemia Patient Meets Bone Marrow Donor Who Saved His Life

IMG_0499.JPG

Leukemia survivor Michael Beltrame, a 42-year-old father of three, owes his life to a complete stranger who altruistically donated bone marrow cells for Mr. Beltrame’s successful bone marrow transplant. Mr. Beltrame met his donor for the first time during Loyola Medicine’s annual Bone Marrow Transplant Celebration.

Medicine

Channels:

Aravinda Chakravarti, Chakravarti, Ehret, Blood Pressure, Genome

New Studies Double Number of Known Sites in Genome Linked to High Blood Pressure

DNA_Microarray_Chip_iStock_1168371.jpg

Several large international groups of researchers report data that more than doubles the number of sites in the human genome tied to blood pressure regulation. One of the studies, by Johns Hopkins University scientists in collaboration with many other groups, turned up unexpected hints that biochemical signals controlling blood pressure may spring from within cells that line blood vessels themselves.

Science

Channels:

Meningitis, Children's Hospital Oakland, Meningitis Vaccine

CHORI Study Reveals Potential Improvements for Effectiveness of Meningococcal Vaccines

A study conducted by UCSF Benioff Children's Hospital Oakland Research Institute (CHORI) scientists shows greatly improved protective antibody responses to a new mutant vaccine antigen for prevention of disease caused by Neisseria meningitidis - also known as meningococcus - that has the potential to improve the current vaccines for meningitis.

Medicine

Channels:

Hemoglobin screening, smartphone apps

HemaApp screens for anemia, blood conditions without needle sticks

UW engineers have developed HemaApp, which uses a smartphone camera and other lighting sources to estimate hemoglobin concentrations and screen for anemia without sticking patients with needles.

Medicine

Channels:

Nosebleed, bloody nose, Hemorrhagic Teangiectasia, HHT

Simple Saline Spray Could Be As Effective As Drug Therapy for Treating Chronic Nosebleeds

UUHC_160829_0505.jpg

Squirting a simple saline solution into the nose twice a day could alleviate chronic nosebleeds just as effectively as spraying with any one of three different medications, reports a study led by Kevin Whitehead, M.D., F.A.H.A., at the University of Utah School of Medicine and published online in the Journal of the American Medical Association (JAMA). The research highlights that there could be benefit to even the simplest of interventions.

Medicine

Channels:

Nasal Sprays Not Effective in Reducing Duration, Frequency of Nosebleeds Caused by Blood Vessel Disorder

Two studies appearing in the September 6 issue of JAMA examine the effectiveness of nasal sprays to reduce the frequency and duration of nosebleeds caused by hereditary hemorrhagic telangiectasia.

Medicine

Channels:

Blood Sugar, Diabetes Complications, diabetes treatment, Endocrinology, evidence based med, Glycemic Control, Medical Research, Minnesota News Release, news release, re, Type 2 Diabetes

Tight Focus on Blood Sugar Narrows Options for Diabetes Complications

ROCHESTER, Minn. – The glucocentric focus on lowering blood sugar in Type 2 diabetes may have short-circuited development of new diabetes therapies, according to a new paper published by Mayo Clinic researchers in the journal Circulation: Cardiovascular Quality and Outcomes.







Chat now!